Sakir Mutevelic, MD, Curium's Chief Medical Officer said: "The completion of enrollment of the SOLAR-RECUR trial is yet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback